Strategem Capital Corporation Class A (SGE)

Overview

Siegfried Holding AG, founded in 1873 and headquartered in Zofingen, Switzerland, operates globally, providing a comprehensive range of services to the pharmaceutical industry. The company specializes in contract development and manufacturing, offering a wide array of solutions across active pharmaceutical ingredients (APIs) and finished dosage forms. It caters to various pharmaceutical needs through its subsidiaries, ensuring a seamless process from development to commercial manufacturing and packaging. Siegfried Holding AG stands as a vital partner to the pharmaceutical sector, leveraging its extensive experience and technological capabilities to deliver high-quality, innovative products and services.

Products and Services

• Pharmaceutical and Analytical Development - Siegfried provides comprehensive development services, including pharmaceutical formulation and analytical development coupled with process and analytical transfer capabilities, ensuring products meet the highest quality standards.
• Commercial Manufacturing and Packaging - The company offers large-scale manufacturing services for APIs and finished dosage forms, as well as packaging solutions that comply with global regulations, supporting products from concept to consumer.
• Scale-up and Clinical Trial Material Production - Specializing in the production of materials for clinical trials, Siegfried facilitates the transition from small-scale development to commercial-scale manufacturing, ensuring the scalability of processes and products.
• APIs and Intermediates Production - It develops and manufactures a wide range of high-quality APIs and intermediates, serving as the backbone for a vast number of pharmaceutical products.
• Finished Dosage Forms - The company produces a variety of finished dosage forms, including solid oral, injectables (sterile and aseptic), ophthalmics, and inhalative products, catering to multiple therapeutic areas and delivery requirements.
• APIs and Controlled Substances - Siegfried focuses on anesthetics, pain and addiction treatment, and treatments for central nervous and respiratory diseases, including caffeine for human health and nutrition.
• Exclusive Synthesis Services - Offering specialized services in process and chemical development, analytical development, pilot manufacturing and scale-up, and commercial manufacturing, tailored to the specific needs of clients.
• Viral Vector Manufacturing Solutions - The company provides cutting-edge solutions for the manufacturing of viral vectors, critical components in gene therapy and vaccine development.
• Licensing, Registration Dossiers, and Common Technical Document Preparation - Siegfried assists with the licensing of oral solid and sterile products, assembles registration dossiers, and prepares common technical documents to facilitate market entry and compliance.